Characterization of rat liver lysosomal cathepsin A1.
D000818:Animals; D000838:Anions; D002403:Cathepsins / Q000037:antagonists & inhibitors / Q000378:metabolism*; D002413:Cations, Divalent; D002729:Chloromercuribenzoates / Q000494:pharmacology; D004151:Dipeptides; D004229:Dithiothreitol / Q000494:pharmacology; D004492:Edetic Acid / Q000494:pharmacology; D004591:Electrophoresis, Polyacrylamide Gel; D004789:Enzyme Activation; D005934:Glucagon; D006454:Hemoglobins; D006863:Hydrogen-Ion Concentration; D007328:Insulin; D007531:Isoflurophate / Q000494:pharmacology; D007700:Kinetics; D008099:Liver / Q000166:cytology / Q000201:enzymology*; D008247:Lysosomes / Q000201:enzymology*; D009842:Oligopeptides; D010618:Phenanthrolines / Q000494:pharmacology; D051381:Rats; D013329:Structure-Activity Relationship
D000838:Anions; D002413:Cations, Divalent; D002729:Chloromercuribenzoates; D004151:Dipeptides; D006454:Hemoglobins; D007328:Insulin; D009842:Oligopeptides; D010618:Phenanthrolines; D007531:Isoflurophate; D005934:Glucagon; D004492:Edetic Acid; D002403:Cathepsins; D004229:Dithiothreitol